News articles about Alphatec Holdings (NASDAQ:ATEC) have trended somewhat positive this week, Accern reports. The research group identifies positive and negative news coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Alphatec Holdings earned a daily sentiment score of 0.08 on Accern’s scale. Accern also gave press coverage about the medical technology company an impact score of 45.5031008210826 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

A number of analysts have recently issued reports on the stock. ValuEngine downgraded shares of Alphatec Holdings from a “sell” rating to a “strong sell” rating in a report on Thursday, August 17th. HC Wainwright assumed coverage on shares of Alphatec Holdings in a report on Monday, August 14th. They set a “buy” rating and a $4.00 price target for the company.

Shares of Alphatec Holdings (NASDAQ ATEC) opened at 2.10 on Wednesday. Alphatec Holdings has a 12-month low of $1.58 and a 12-month high of $9.65. The company has a 50-day moving average of $1.98 and a 200 day moving average of $2.11. The firm’s market cap is $23.20 million.

Alphatec Holdings (NASDAQ:ATEC) last issued its quarterly earnings results on Thursday, August 10th. The medical technology company reported ($0.32) EPS for the quarter. The company had revenue of $24.38 million for the quarter. Equities research analysts anticipate that Alphatec Holdings will post ($1.20) earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Alphatec Holdings (ATEC) Receives Daily News Sentiment Score of 0.08” was originally reported by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another publication, it was copied illegally and republished in violation of United States and international copyright & trademark laws. The original version of this story can be accessed at

Alphatec Holdings Company Profile

Alphatec Holdings, Inc is a medical technology company. The Company through its subsidiary, Alphatec Spine, Inc and its subsidiaries, designs, develops, manufactures and markets products for the surgical treatment of spine disorders. Its product portfolio and pipeline addresses the cervical, thoracolumbar and intervertebral regions of the spine and covers a range of spinal disorders and surgical procedures.

Insider Buying and Selling by Quarter for Alphatec Holdings (NASDAQ:ATEC)

Receive News & Ratings for Alphatec Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alphatec Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.